{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:48:30Z","timestamp":1794278910799,"version":"4.9.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"State Research Programme","award":["VPP-EM-BIOMEDIC\u012aNA-2022\/1-0001"],"award-info":[{"award-number":["VPP-EM-BIOMEDIC\u012aNA-2022\/1-0001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04739-y","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:35:26Z","timestamp":1761204926000},"page":"4569-4587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Active immunization with bacteriophage AP205 VLPs results in reduced amyloid load and microgliosis in 5xFAD female mice"],"prefix":"10.1007","volume":"399","author":[{"given":"Vladimirs","family":"Pilipenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilva","family":"Lieknina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dace","family":"Skrastina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selen","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrise Luize","family":"Revina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Upite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiba","family":"Jansone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaspars","family":"Tars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"4739_CR1","doi-asserted-by":"publisher","first-page":"7613","DOI":"10.4049\/jimmunol.0803366","volume":"182","author":"P Bach","year":"2009","unstructured":"Bach P, Tsch\u00e4pe J-A, Kopietz F, Braun G, Baade JK, Wiederhold K-H, Staufenbiel M, Prinz M, Deller T, Kalinke U, Buchholz CJ, M\u00fcller UC (2009) Vaccination with A\u03b2-displaying virus-like particles reduces soluble and insoluble cerebral A\u03b2 and lowers plaque burden in APP transgenic mice. J Immunol 182:7613\u20137624","journal-title":"J Immunol"},{"key":"4739_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.mito.2020.11.008","volume":"56","author":"S Chadha","year":"2021","unstructured":"Chadha S, Behl T, Sehgal A, Kumar A, Bungau S (2021) Exploring the role of mitochondrial proteins as molecular target in Alzheimer\u2019s disease. Mitochondrion 56:62\u201372","journal-title":"Mitochondrion"},{"key":"4739_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14:32","journal-title":"Mol Neurodegener"},{"key":"4739_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41541-024-00942-9","volume":"9","author":"X Feng","year":"2024","unstructured":"Feng X, Hou Y, Liu J, Yan F, Dai M, Chen M, Wang J, Li J, Liu Z, Sun D, Zhang Y, Yu X, Kong W, Wu H (2024) A multi-targeting immunotherapy ameliorates multiple facets of Alzheimer\u2019s disease in 3xTg mice. NPJ Vaccines 9:153","journal-title":"NPJ Vaccines"},{"key":"4739_CR5","doi-asserted-by":"publisher","first-page":"41041","DOI":"10.1038\/srep41041","volume":"7","author":"L Fu","year":"2017","unstructured":"Fu L, Li Y, Hu Y, Zheng Y, Yu B, Zhang H, Wu J, Wu H, Yu X, Kong W (2017) Norovirus P particle-based active A\u03b2 immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer\u2019s disease. Sci Rep 7:41041","journal-title":"Sci Rep"},{"key":"4739_CR6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2210766119","author":"M Habashi","year":"2022","unstructured":"Habashi M, Vutla S, Tripathi K, Senapati S, Chauhan PS, Haviv-Chesner A, Richman M, Mohand S-A, Dumulon-Perreault V, Mulamreddy R, Okun E, Chill JH, Gu\u00e9rin B, Lubell WD, Rahimipour S (2022) Early diagnosis and treatment of Alzheimer\u2019s disease by targeting toxic soluble A\u03b2 oligomers. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2210766119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4739_CR7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","volume":"372","author":"C Holmes","year":"2008","unstructured":"Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JA (2008) Long-term effects of A\u03b242 immunisation in Alzheimer\u2019s disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372:216\u2013223","journal-title":"Lancet"},{"key":"4739_CR8","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1016\/j.vaccine.2021.07.023","volume":"39","author":"T Illouz","year":"2021","unstructured":"Illouz T, Madar R, Hirsh T, Biragyn A, Okun E (2021) Induction of an effective anti-Amyloid-\u03b2 humoral response in aged mice. Vaccine 39:4817\u20134829","journal-title":"Vaccine"},{"key":"4739_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1515\/BC.2008.064","volume":"389","author":"GT Jennings","year":"2008","unstructured":"Jennings GT, Bachmann MF (2008) The coming of age of virus-like particle vaccines. Bchm 389:521\u2013536","journal-title":"Bchm"},{"key":"4739_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020197","author":"A Kirsteina","year":"2020","unstructured":"Kirsteina A, Akopjana I, Bogans J, Lieknina I, Jansons J, Skrastina D, Kazaka T, Tars K, Isakova-Sivak I, Mezhenskaya D, Kotomina T, Matyushenko V, Rudenko L, Kazaks A (2020) Construction and immunogenicity of a novel multivalent vaccine prototype based on conserved influenza virus antigens. Vaccines. https:\/\/doi.org\/10.3390\/vaccines8020197","journal-title":"Vaccines"},{"key":"4739_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12951-019-0497-8","volume":"17","author":"I Liekni\u0146a","year":"2019","unstructured":"Liekni\u0146a I, Kalni\u0146\u0161 G, Akopjana I, Bogans J, \u0160i\u0161ovs M, Jansons J, R\u016bmnieks J, T\u0101rs K (2019) Production and characterization of novel ssRNA bacteriophage virus-like particles from metagenomic sequencing data. J Nanobiotechnol 17:61","journal-title":"J Nanobiotechnol"},{"key":"4739_CR12","doi-asserted-by":"crossref","unstructured":"Lim LWC, Lee JY, Chen CH, Voon KGL, Koh RY, Chye SM (2024) Virus-like Particles-Based Vaccine to Combat Neurodegenerative Diseases. Curr Pharm Biotechnol 26,.","DOI":"10.2174\/0113892010331763241002122854"},{"key":"4739_CR13","doi-asserted-by":"publisher","first-page":"414","DOI":"10.14283\/jpad.2021.56","volume":"8","author":"SL Lowe","year":"2021","unstructured":"Lowe SL, Duggan Evans C, Shcherbinin S, Cheng Y-J, Willis BA, Gueorguieva I, Lo AC, Fleisher AS, Dage JL, Ardayfio P, Aguiar G, Ishibai M, Takaichi G, Chua L, Mullins G, Sims JR (2021) Donanemab (LY3002813) phase 1b study in Alzheimer\u2019s disease: rapid and sustained reduction of brain amyloid measured by florbetapir F18 imaging. J Prev Alzheimers Dis 8:414\u2013424","journal-title":"J Prev Alzheimers Dis"},{"key":"4739_CR14","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, Abdoli A, Abualhasan A, Abu-Gharbieh E, Akram TT, Al Hamad H, Alahdab F, Alanezi FM, Alipour V, Almustanyir S, Amu H, Ansari I, Arabloo J, Ashraf T, Astell-Burt T, Ayano G, Ayuso-Mateos JL, Baig AA, Barnett A, Barrow A, Baune BT, B\u00e9jot Y, Bezabhe WMM, Bezabih YM, Bhagavathula AS, Bhaskar S, Bhattacharyya K, Bijani A, Biswas A, Bolla SR, Boloor A, Brayne C, Brenner H, Burkart K, Burns RA, C\u00e1mera LA, Cao C, Carvalho F, Castro-de-Araujo LFS, Catal\u00e1-L\u00f3pez F, Cerin E, Chavan PP, Cherbuin N, Chu D-T, Costa VM, Couto RAS, Dadras O, Dai X, Dandona L, Dandona R, De la Cruz-G\u00f3ngora V, Dhamnetiya D, Dias da Silva D, Diaz D, Douiri A, Edvardsson D, Ekholuenetale M, El Sayed I, El-Jaafary SI, Eskandari K, Eskandarieh S, Esmaeilnejad S, Fares J, Faro A, Farooque U, Feigin VL, Feng X, Fereshtehnejad S-M, Fernandes E, Ferrara P, Filip I, Fillit H, Fischer F, Gaidhane S, Galluzzo L, Ghashghaee A, Ghith N, Gialluisi A, Gilani SA, Glavan I-R, Gnedovskaya EV, Golechha M, Gupta R, Gupta VB, Gupta VK, Haider MR, Hall BJ, Hamidi S, Hanif A, Hankey GJ, Haque S, Hartono RK, Hasaballah AI, Hasan MT, Hassan A, Hay SI, Hayat K, Hegazy MI, Heidari G, Heidari-Soureshjani R, Herteliu C, Househ M, Hussain R, Hwang B-F, Iacoviello L, Iavicoli I, Ilesanmi OS, Ilic IM, Ilic MD, Irvani SSN, Iso H, Iwagami M, Jabbarinejad R, Jacob L, Jain V, Jayapal SK, Jayawardena R, Jha RP, Jonas JB, Joseph N, Kalani R, Kandel A, Kandel H, Karch A, Kasa AS, Kassie GM, Keshavarz P, Khan MA, Khatib MN, Khoja TAM, Khubchandani J, Kim MS, Kim YJ, Kisa A, Kisa S, Kivim\u00e4ki M, Koroshetz WJ, Koyanagi A, Kumar GA, Kumar M, Lak HM, Leonardi M, Li B, Lim SS, Liu X, Liu Y, Logroscino G, Lorkowski S, Lucchetti G, Lutzky Saute R, Magnani FG, Malik AA, Massano J, Mehndiratta MM, Menezes RG, Meretoja A, Mohajer B, Mohamed Ibrahim N, Mohammad Y, Mohammed A, Mokdad AH, Mondello S, Moni MAA, Moniruzzaman M, Mossie TB, Nagel G, Naveed M, Nayak VC, Neupane Kandel S, Nguyen TH, Oancea B, Otstavnov N, Otstavnov SS, Owolabi MO, Panda-Jonas S, Pashazadeh Kan F, Pasovic M, Patel UK, Pathak M, Peres MFP, Perianayagam A, Peterson CB, Phillips MR, Pinheiro M, Piradov MA, Pond CD, Potashman MH, Pottoo FH, Prada SI, Radfar A, Raggi A, Rahim F, Rahman M, Ram P, Ranasinghe P, Rawaf DL, Rawaf S, Rezaei N, Rezapour A, Robinson SR, Romoli M, Roshandel G, Sahathevan R, Sahebkar A, Sahraian MA, Sathian B, Sattin D, Sawhney M, Saylan M, Schiavolin S, Seylani A, Sha F, Shaikh MA, Shaji K, Shannawaz M, Shetty JK, Shigematsu M, Il SJ, Shiri R, Silva DAS, Silva JP, Silva R, Singh JA, Skryabin VY, Skryabina AA, Smith AE, Soshnikov S, Spurlock EE, Stein DJ, Sun J, Tabar\u00e9s-Seisdedos R, Thakur B, Timalsina B, Tovani-Palone MR, Tran BX, Tsegaye GW, Valadan Tahbaz S, Valdez PR, Venketasubramanian N, Vlassov V, Vu GT, Vu LG, Wang Y-P, Wimo A, Winkler AS, Yadav L, Yahyazadeh Jabbari SH, Yamagishi K, Yang L, Yano Y, Yonemoto N, Yu C, Yunusa I, Zadey S, Zastrozhin MS, Zastrozhina A, Zhang Z-J, Murray CJL, Vos T (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7:e105\u2013e125","journal-title":"Lancet Public Health"},{"key":"4739_CR15","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos and Watson","year":"2007","unstructured":"Paxinos and Watson (2007) The Rat Brain in Stereotaxic Coordinates, 6th edn. Academic Press, Cambridge, MA, USA","edition":"6"},{"key":"4739_CR16","doi-asserted-by":"crossref","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, W\u00fcrbel H (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol 18:e3000410.","DOI":"10.1371\/journal.pbio.3000410"},{"key":"4739_CR17","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/cells12050780","volume":"12","author":"CH Poon","year":"2023","unstructured":"Poon CH, Wong STN, Roy J, Wang Y, Chan HWH, Steinbusch H, Blokland A, Temel Y, Aquili L, Lim LW (2023) Sex differences between neuronal loss and the early onset of amyloid deposits and behavioral consequences in 5xFAD transgenic mouse as a model for Alzheimer\u2019s disease. Cells 12:780","journal-title":"Cells"},{"key":"4739_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000449503","volume":"59","author":"P Pumpens","year":"2016","unstructured":"Pumpens P, Renhofa R, Dishlers A, Kozlovska T, Ose V, Pushko P, Tars K, Grens E, Bachmann MF (2016) The true story and advantages of RNA phage capsids as nanotools. Intervirology 59:74\u2013110","journal-title":"Intervirology"},{"key":"4739_CR19","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1586\/erv.10.115","volume":"9","author":"A Rold\u00e3o","year":"2010","unstructured":"Rold\u00e3o A, Mellado MCM, Castilho LR, Carrondo MJ, Alves PM (2010) Virus-like particles in vaccine development. Expert Rev Vaccines 9:1149\u20131176","journal-title":"Expert Rev Vaccines"},{"key":"4739_CR20","doi-asserted-by":"publisher","first-page":"a006189\u2013a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1:a006189\u2013a006189","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4739_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1096\/fj.12-217497","volume":"27","author":"V Shukla","year":"2013","unstructured":"Shukla V, Zheng Y, Mishra SK, Amin ND, Steiner J, Grant P, Kesavapany S, Pant HC (2013) A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer\u2019s disease phenotypes in model mice. FASEB J 27:174\u2013186","journal-title":"FASEB J"},{"key":"4739_CR22","doi-asserted-by":"crossref","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, Ritchie C, Brooks DA, Mintun M, Skovronsky DM, TRAILBLAZER-ALZ 2 Investigators (2023) Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA 330:512\u2013527","DOI":"10.1001\/jama.2023.13239"},{"key":"4739_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40035-022-00292-3","volume":"11","author":"C Song","year":"2022","unstructured":"Song C, Shi J, Zhang P, Zhang Y, Xu J, Zhao L, Zhang R, Wang H, Chen H (2022) Immunotherapy for Alzheimer\u2019s disease: targeting \u03b2-amyloid and beyond. Transl Neurodegener 11:18","journal-title":"Transl Neurodegener"},{"key":"4739_CR24","doi-asserted-by":"publisher","first-page":"111195","DOI":"10.1016\/j.mad.2019.111195","volume":"185","author":"S Todorovic","year":"2020","unstructured":"Todorovic S, Loncarevic-Vasiljkovic N, Jovic M, Sokanovic S, Kanazir S, Mladenovic Djordjevic A (2020) Frailty index and phenotype frailty score: sex- and age-related differences in 5XFAD transgenic mouse model of Alzheimer\u2019s disease. Mech Ageing Dev 185:111195","journal-title":"Mech Ageing Dev"},{"key":"4739_CR25","doi-asserted-by":"crossref","unstructured":"Usman MB, Bhardwaj S, Roychoudhury S, Kumar D, Alexiou A, Kumar P, Ambasta RK, Prasher P, Shukla S, Upadhye V, Khan FA, Awasthi R, Shastri MD, Singh SK, Gupta G, Chellappan DK, Dua K, Jha SK, Ruokolainen J, Kesari KK, Ojha S, Jha NK (2021) Immunotherapy for alzheimer\u2019s disease: current scenario and future perspectives. J Prev Alzheimers Dis 1\u201318","DOI":"10.14283\/jpad.2021.52"},{"key":"4739_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388:9\u201321","journal-title":"N Engl J Med"},{"key":"4739_CR27","doi-asserted-by":"publisher","first-page":"9323","DOI":"10.1523\/JNEUROSCI.0293-11.2011","volume":"31","author":"C Wiessner","year":"2011","unstructured":"Wiessner C, Wiederhold K-H, Tissot AC, Frey P, Danner S, Jacobson LH, Jennings GT, Luond R, Ortmann R, Reichwald J, Zurini M, Mir A, Bachmann MF, Staufenbiel M (2011) The second-generation active A immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects. J Neurosci 31:9323\u20139331","journal-title":"J Neurosci"},{"key":"4739_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1474-4422(12)70140-0","volume":"11","author":"B Winblad","year":"2012","unstructured":"Winblad B, Andreasen N, Minthon L, Floesser A, Imbert G, Dumortier T, Maguire RP, Blennow K, Lundmark J, Staufenbiel M, Orgogozo J-M, Graf A (2012) Safety, tolerability, and antibody response of active A\u03b2 immunotherapy with CAD106 in patients with Alzheimer\u2019s disease: randomised, double-blind, placebo-controlled, first-in-human study. Lancet Neurol 11:597\u2013604","journal-title":"Lancet Neurol"},{"key":"4739_CR29","doi-asserted-by":"publisher","first-page":"41517","DOI":"10.1074\/jbc.M110.178707","volume":"285","author":"O Wirths","year":"2010","unstructured":"Wirths O, Erck C, Martens H, Harmeier A, Geumann C, Jawhar S, Kumar S, Multhaup G, Walter J, Ingelsson M, Degerman-Gunnarsson M, Kalimo H, Huitinga I, Lannfelt L, Bayer TA (2010) Identification of low molecular weight pyroglutamate A\u03b2 oligomers in Alzheimer disease. J Biol Chem 285:41517\u201341524","journal-title":"J Biol Chem"},{"issue":"12","key":"4739_CR30","doi-asserted-by":"publisher","first-page":"9797","DOI":"10.3390\/ijms24129797","volume":"24","author":"K Zagorski","year":"2023","unstructured":"Zagorski K, King O, Hovakimyan A, Petrushina I, Antonyan T, Chailyan G, Ghazaryan M, Hyrc KL, Chadarevian JP, Davtyan H, Blurton-Jones M, Cribbs DH, Agadjanyan MG, Ghochikyan A (2023) Novel vaccine against pathological pyroglutamate-modified amyloid beta for prevention of Alzheimer\u2019s disease. Int J Mol Sci 24(12):9797","journal-title":"Int J Mol Sci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04739-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04739-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04739-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T08:00:39Z","timestamp":1772006439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04739-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4739"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04739-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}